Sigma Healthcare Limited (SIG.AX) stock analysis

In our weekly check, Sigma Healthcare Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 3.

About Sigma Healthcare Limited

Sigma Healthcare Limited is a Healthcare company (Medical - Distribution) based in Australia, listed on ASX as SIG.AX.

What our checks show for SIG.AX

Red flags

• The stock has fallen as much as 87% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 13.3 years.
• The share count grew by 1023% in 2 years: each shareholder owns a smaller slice.

Warning signs

• The net margin is only 6.5%: little room if costs rise.
• Free cash flow is only 4.8% of revenue.
• The dividend takes 76% of profit: little cushion if profit falls.

Strengths

• The net margin rose by 6.8 points over 5 years, to 6.5%.
• The gross margin is 18.1% and has risen by 12.3 points: pricing power is holding.
• Analysts expect earnings per share to grow about 17.5% a year over the next years.
• Revenue grew 43.6% a year over the last 3 years.
• Earnings per share grew 225% a year over the last 3 years.
• Net profit grew 632% a year over the last 3 years.

Similar companies

1099.HK · CAH · COR · HSIC · MCK · GALE.SW

Questions

What grade does Sigma Healthcare Limited (SIG.AX) have?

In our weekly check, Sigma Healthcare Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 3, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SIG.AX stock?

This week's biggest flags for Sigma Healthcare Limited: Deep past fall, Slow recovery after falls, Share dilution. In total 6 of 25 checks show a warning or a red flag.

What does Sigma Healthcare Limited do?

Sigma Healthcare Limited is a Healthcare company (Medical - Distribution) based in Australia, listed on ASX as SIG.AX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis